Immune reactivity to Trypanosoma cruzi chimeric proteins for Chagas disease diagnosis in immigrants living in a non-endemic setting

Autor: Dopico, Eva, Del-Rei, Rodrigo Pimenta, Espinoza, Bertha, Ubillos, Itziar, Zanchin, Nilson Ivo Tonin, Sulleiro Igual, Elena, Moure García, Zaira, Celedon, Paola Alejandra Fiorani, Souza, Wayner Vieira, da Silva, Edimilson Domingos, Gomes, Yara Miranda, Santos, Fred Luciano Neves, Universitat Autònoma de Barcelona
Přispěvatelé: Institut Català de la Salut, [Dopico E, Ubillos I] Laboratori Clínic Territorial Metropolitana Sud, Institut Català de la Salut, Barcelona, Spain. [Del-Rei RP] Faculty of Technology and Sciences of Bahia, Salvador, Bahia, Brazil. [Espinoza B] Instituto de Investigaciones Biomédicas, Departamento de Inmunología, Universidad Nacional Autónoma de México, Ciudad de México, Mexico. [Zanchin NIT] Carlos Chagas Institute, Oswaldo Cruz Foundation, Curitiba, Paraná, Brazil. [Sulleiro E, Moure Z] Servei de Microbiologia, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Vall d'Hebron Barcelona Hospital Campus
Jazyk: angličtina
Rok vydání: 2019
Předmět:
0301 basic medicine
Male
Chimeric antigens
Chagas disease
Antibodies
Protozoan

Chagas
Malaltia de - Barcelona

Serology
enfermedades parasitarias::infecciones por protozoos::infecciones por Euglenozoa::tripanosomiasis::enfermedad de Chagas [ENFERMEDADES]
Other subheadings::/statistics & numerical data [Other subheadings]
0302 clinical medicine
Immigrants - Malalties - Diagnòstic
Pregnancy
Medicine
Persons::Emigrants and Immigrants [NAMED GROUPS]
Otros calificadores::/estadística & datos numéricos [Otros calificadores]
030212 general & internal medicine
personas::emigrantes e inmigrantes [DENOMINACIONES DE GRUPOS]
Accuracy
Immunoassay
biology
Antígens - Immunologia
Infectious Diseases
Female
Antibody
Toxoplasma
Parasitic Diseases::Protozoan Infections::Euglenozoa Infections::Trypanosomiasis::Chagas Disease [DISEASES]
Research Article
Barcelona
Adult
Trypanosoma cruzi
030106 microbiology
Emigrants and Immigrants
Antigens
Protozoan

Enzyme-Linked Immunosorbent Assay
Cross Reactions
Sensitivity and Specificity
lcsh:Infectious and parasitic diseases
03 medical and health sciences
Antigen
parasitic diseases
Humans
lcsh:RC109-216
Biological Factors::Antigens::Antigens
Protozoan [CHEMICALS AND DRUGS]

business.industry
Toxoplasma gondii
biology.organism_classification
medicine.disease
Parasitology
Spain
Immunology
biology.protein
business
Trypanosomiasis
factores biológicos::antígenos::antígenos protozoarios [COMPUESTOS QUÍMICOS Y DROGAS]
Zdroj: Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-7 (2019)
BMC Infectious Diseases
Scientia
Popis: Chagas disease; Chimeric antigens; Trypanosoma cruzi Malaltia de Chagas; Antígens quimèrics; Trypanosoma cruzi Enfermedad de Chagas; Antígenos quiméricos; Trypanosoma cruzi BACKGROUND: Chronic Chagas Disease (CD) diagnosis is based on serological methods employing crude, semipurified or recombinant antigens, which may result in low sensitivity or cross-reactivity. To reduce these restrictions, we developed a strategy involving use of molecules containing repetitive fragments of Trypanosoma cruzi conserved proteins. Diagnostic performance of IBMP-8.1 and IBMP-8.4 chimeric antigens (Molecular Biology Institute of Paraná - IBMP in Portuguese acronym) was assessed to diagnose T. cruzi-infected and non-infected immigrants living in Barcelona (Spain), a non-endemic setting for Chagas disease. METHODS: Reactivity of IBMP-8.1 and IBMP-8.4 was assessed using an in-house automated ELISA with 347 positive and 331 negative individuals to Chagas disease. Antigenic cross-reactivity was measured with sera samples from pregnant women with Toxoplasma gondii (n = 98) and Zika virus (n = 75) antibodies. RESULTS: The area under the curve values was 1 and 0.99 for the IBMP-8.1 and IBMP-8.4 proteins, respectively, demonstrating excellent diagnostic accuracy. The reactivity index was higher for IBMP-8.1 than IBMP-8.4 in positive samples and no significant difference in reactivity index was observed in negative samples. Sensitivity ranged from 99.4% for IBMP-8.1 to 99.1% for IBMP-8.4 and was not statistically different. Specificity for IBMP-8.1 reached 100 and 99.7% for IBMP-8.4, both nearly 100% accurate. No antigenic cross-reactivity was observed and reactivity index was similar to that for negative Chagas disease individuals. CONCLUSIONS: Our results showed an outstanding performance of IBMP-8.1 and IBMP-8.4 chimeric antigens by ELISA and suggest both chimeric antigens could also be used for Chagas disease diagnosis in immigrants living in non-endemic settings.
Databáze: OpenAIRE